These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 9193630

  • 1. Treatment of murine cardiac allograft by monoclonal antibodies to IL-2 receptor alpha chain and beta chain.
    Isobe M, Suzuki J, Okubo Y, Horie S, Tanaka T, Miyasaka M, Sekiguchi M.
    Transplant Proc; 1997 Jun; 29(4):2301-2. PubMed ID: 9193630
    [No Abstract] [Full Text] [Related]

  • 2. Prolongation of murine cardiac allograft survival by the anti-interleukin-2 receptor monoclonal antibody AMT-13.
    Kirkman RL, Barrett LV, Koltun WA, Diamantstein T.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):618-9. PubMed ID: 3274828
    [No Abstract] [Full Text] [Related]

  • 3. Differential effect of an anti-CD8 monoclonal antibody on rejection of murine intestine and cardiac allografts.
    He G, Kim OS, Thistlethwaite JR, Hart J, Siegel CT, Szot GL, Newell KA.
    Transplant Proc; 1999 Feb; 31(1-2):1239-41. PubMed ID: 10083553
    [No Abstract] [Full Text] [Related]

  • 4. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
    Isobe M, Suzuki J, Yagita H, Okumura K, Sekiguchi M.
    Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478
    [No Abstract] [Full Text] [Related]

  • 5. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
    Isobe M, Suzuki J, Yamazaki S, Sekiguchi M.
    Transplant Proc; 1996 Apr; 28(2):1045-6. PubMed ID: 8623222
    [No Abstract] [Full Text] [Related]

  • 6. Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival.
    Tinubu SA, Hakimi J, Kondas JA, Bailon P, Familletti PC, Spence C, Crittenden MD, Parenteau GL, Dirbas FM, Tsudo M.
    J Immunol; 1994 Nov 01; 153(9):4330-8. PubMed ID: 7930631
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice.
    Lowry RP, Konieczny B, Alexander D, Larsen C, Pearson T, Smith S, Narula S.
    Transplant Proc; 1995 Feb 01; 27(1):392-4. PubMed ID: 7879034
    [No Abstract] [Full Text] [Related]

  • 8. Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation.
    Isobe M, Ihara A.
    Transplant Proc; 1993 Feb 01; 25(1 Pt 2):1079-80. PubMed ID: 8095106
    [No Abstract] [Full Text] [Related]

  • 9. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice.
    Bashuda H, Seino K, Kano M, Sato K, Azuma M, Yagita H, Okumura K.
    Transplant Proc; 1996 Apr 01; 28(2):1039-41. PubMed ID: 8623220
    [No Abstract] [Full Text] [Related]

  • 10. Immunosuppression by inhibition of cellular adhesion mediated by leukocyte function-associated antigen-1/intercellular adhesion molecule-1 in murine cardiac transplantation.
    Xu XY, Honjo K, Devore-Carter D, Bucy RP.
    Transplantation; 1997 Mar 27; 63(6):876-85. PubMed ID: 9089229
    [Abstract] [Full Text] [Related]

  • 11. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody.
    Orosz CG, Wakely E, Sedmak DD, Bergese SD, VanBuskirk AM.
    Transplantation; 1997 Apr 27; 63(8):1109-17. PubMed ID: 9133472
    [Abstract] [Full Text] [Related]

  • 12. Prolongation of fetal pancreas allograft survival in mice treated with anti-IL-2 receptor monoclonal antibody (PC61) conjugated with idarubicin.
    Koulmanda M, Pietersz G, McKenzie IF, Mandel TE.
    Transplant Proc; 1990 Oct 27; 22(5):2113-4. PubMed ID: 2219312
    [No Abstract] [Full Text] [Related]

  • 13. Pretreatment with cyclosporin A (CyA) and anti-interleukin 2 receptor monoclonal antibody (IL-2R MAb) abrogates the anti-idiotype response in rat recipients of cardiac allografts.
    Tanaka K, Kupiec-Weglinski JW, Hancock WW, Stunkel K, Diamantstein T, Tilney NL.
    Transplant Proc; 1991 Feb 27; 23(1 Pt 1):281-2. PubMed ID: 1990532
    [No Abstract] [Full Text] [Related]

  • 14. Induction of transplantation tolerance by treatment with ICAM-1 antisense oligonucleotides and anti-LFA-1 monoclonal antibodies.
    Stepkowski SM, Tu Y, Condon TP, Bennett CF.
    Transplant Proc; 1995 Feb 27; 27(1):113. PubMed ID: 7878822
    [No Abstract] [Full Text] [Related]

  • 15. Monoclonal antibody to anti-VCAM-1 interferes with murine cardiac allograft rejection.
    Pelletier R, Ohye R, Kincade P, Ferguson R, Orosz C.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):839-41. PubMed ID: 7679845
    [No Abstract] [Full Text] [Related]

  • 16. Anti-CD45RB treatment prolongs islet allograft survival in mice.
    Auersvald LA, Rothstein DM, Oliveira SC, Khuong CQ, Basadonna GP.
    Transplant Proc; 1997 Feb 27; 29(1-2):771. PubMed ID: 9123520
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of monoclonal antibody to VLA-4 on corneal allograft survival in mice.
    Hori J, Yamagami S, Obata H, Tsuru T, Isobe M.
    Transplant Proc; 1996 Jun 27; 28(3):1990-1. PubMed ID: 8658970
    [No Abstract] [Full Text] [Related]

  • 20. Immunosuppression by aminopterin or idarubicin conjugated to anti-CD8 in the mouse heart allograft model.
    Mottram PL, Pietersz GA, Purcell LJ, Krauer K, McKenzie IF.
    Transplant Proc; 1992 Oct 27; 24(5):2301. PubMed ID: 1413068
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.